Shanghai Medicilon Inc.

SHSE:688202 Stock Report

Market Cap: CN¥4.7b

Shanghai Medicilon Future Growth

Future criteria checks 5/6

Shanghai Medicilon is forecast to grow earnings and revenue by 124.4% and 47.2% per annum respectively while EPS is expected to grow by 124.2% per annum.

Key information

124.4%

Earnings growth rate

124.2%

EPS growth rate

Life Sciences earnings growth29.1%
Revenue growth rate47.2%
Future return on equityn/a
Analyst coverage

Low

Last updated27 Jun 2024

Recent future growth updates

No updates

Recent updates

Shanghai Medicilon Inc. (SHSE:688202) Might Not Be As Mispriced As It Looks

Sep 27
Shanghai Medicilon Inc. (SHSE:688202) Might Not Be As Mispriced As It Looks

Is Shanghai Medicilon (SHSE:688202) Weighed On By Its Debt Load?

Jun 07
Is Shanghai Medicilon (SHSE:688202) Weighed On By Its Debt Load?

Market Cool On Shanghai Medicilon Inc.'s (SHSE:688202) Revenues Pushing Shares 27% Lower

Apr 25
Market Cool On Shanghai Medicilon Inc.'s (SHSE:688202) Revenues Pushing Shares 27% Lower

Earnings and Revenue Growth Forecasts

SHSE:688202 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20252,421298N/A3861
12/31/20242,025236N/A2571
6/30/20241,015-270-13020N/A
3/31/20241,174-172-169-8N/A
12/31/20231,366-33-15233N/A
9/30/20231,602175-28317N/A
6/30/20231,788342-424-14N/A
3/31/20231,754363-38412N/A
12/31/20221,659338-425-21N/A
9/30/20221,621379-150205N/A
6/30/20221,42533263330N/A
3/31/20221,30931486380N/A
12/31/20211,167282160453N/A
9/30/20211,01923655292N/A
6/30/202189119610208N/A
3/31/202177515955225N/A
12/31/202066612989208N/A
9/30/20205699521147N/A
6/30/202051186-1123N/A
3/31/202046770-4959N/A
12/31/201944967-3958N/A
9/30/201940764-1372N/A
12/31/201832561771N/A
12/31/201724942N/A75N/A
12/31/201623243N/A34N/A
12/31/201516426N/A36N/A
12/31/2014109-3N/A19N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688202 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).

Earnings vs Market: 688202 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 688202 is expected to become profitable in the next 3 years.

Revenue vs Market: 688202's revenue (47.2% per year) is forecast to grow faster than the CN market (13.5% per year).

High Growth Revenue: 688202's revenue (47.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 688202's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y